CYP21A2 and neoplasm: A total of 33 proteins exhibited significantly different expression levels in cancer patients: 31 proteins displayed increased levels in tumor samples (CAH1, HBD, HBB, LPA, PF4V1, SAA4, APOA1, APOE, HBA1, C1QC, C4BPB, APOC2, VTN, FGA, ORM2, APOB, PROS1, SERPINA3, CLU, APOD, F2, SERPINF2, GPX3, AZGP1, SERPING1, PON1, A2MG, LGALS3BP, AFM, APOA4, and PZP).